arrow
L

Laëtitia Vercellino

Saint-Louis Hospital
H指数:35
被引数:4,503

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study

CAR T细胞疗法期间复发/难治性弥漫大B细胞淋巴瘤的标准化FDG-PET解读:一项DESCAR-T研究

2026-07-250
PRE
Large B-cell Lymphoma: The LYSA pragmatic guidelines

弥漫大B细胞淋巴瘤:LYSA实用性指南

2025-12-030
OAAI
Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials

使用SUV4.0分割阈值测量的代谢肿瘤体积对1960例来自前瞻性LYSA试验的淋巴瘤患者的预后影响

2025-03-200
PRE
Precautions to Consider in the Analysis of Prognostic and Predictive Indices

在分析预后和预测指标时应考虑的注意事项

2024-11-010
OA
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study

基线18F-FDG PET/CT小脑/肝脏指数改善移植后淋巴增生性疾病预后的多中心回顾性研究

2024-05-270
OAAI
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging
RADIOLOGY
IF15.2
2023-01-0124
PRE
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
2022-11-3013
OAAI
18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients

18F-FDG PET最大强度预测和人工智能: 轻松测量DLBCL患者预后生物标志物的双赢组合

2022-06-1625
OAAI
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
2022-06-0924
OAAI
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
2020-11-12274
OAAI